(Q38296275)

1 September 2017

1 reference

title

The therapeutic monoclonal antibody market (English)

1 reference

1 September 2017

1 reference

1 reference

Dawn M Ecker

1

1 reference

1 September 2017

Susan Dana Jones

series ordinal

2

1 reference

1 September 2017

Howard L Levine

series ordinal

3

1 reference

1 September 2017

language of work or name

1 reference

1 January 2015

1 reference

1 September 2017

Monoclonal Antibodies

1 reference

1 September 2017

7

1 reference

1 September 2017

9-14

1 reference

1 September 2017

1

1 reference

Rapid high-throughput characterisation, classification and selection of recombinant mammalian cell line phenotypes using intact cell MALDI-ToF mass spectrometry fingerprinting and PLS-DA modelling

1 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622599

Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622599

High-throughput miniaturized bioreactors for cell culture process development: reproducibility, scalability, and control

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622599

High-throughput process development for biopharmaceutical drug substances

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622599

Trends in risks associated with new drug development: success rates for investigational drugs

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622599

The agony and ecstasy of "OMIC" technologies in drug development

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622599

Production of recombinant protein therapeutics in cultivated mammalian cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622599

Automated dynamic fed-batch process and media optimization for high productivity cell culture process development

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622599

Recombinant protein therapeutics--success rates, market trends and values to 2010.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622599

The availability of glucose to CHO cells affects the intracellular lipid-linked oligosaccharide distribution, site occupancy and the N-glycosylation profile of a monoclonal antibody.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622599

10.4161/19420862.2015.989042

31 August 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference

1 September 2017

1 reference